See the InvisibleSM
Innovating How Neurological Diseases Are Examined
ANNOUNCING
NeuroMatch®
Access U.S. and Korea Release
We are excited to announce the launch of NeuroMatch Access in the United States and Korea, a seamless platform that revolutionizes EEG analysis with faster, more comprehensive results. Offering instant web access to cloud-stored diagnostic data, NeuroMatch enhances collaboration and improves patient care. Key features include artifact reduction, longitudinal patient reports, automated reports, 24-hour trending summaries, and browser-based access with role-based controls, all while adhering to HIPAA regulations.
A leader in cutting edge neural information analysis technology
LVIS is a leader in cutting edge neural information analysis technology that decodes brain networks and provides visualizations assisting neurological disease diagnosis. LVIS owns patented technologies and our team includes leaders with strong expertise in neuroscience and engineering. LVIS has been part of the Stanford StartX program, Stanford Byers Center for Biodesign Faculty Fellowship Program, and the NVIDIA inception program. LVIS is also a recipient of the Stanford Spectrum grant, a LIVA NOVA project grant, and the Epilepsy Foundation research grant. Learn more about LVIS.
LVIS: FELLOWSHIPS & GRANTS
HEALTHCARE CAPACITY
Neurological health is the #1 cause of disability worldwide*
The surging demand for neurological diagnosis and treatment exceeds the capacity of the healthcare system. The imbalance will continue to accelerate driven by an aging population with increased social isolation.
In the United States alone, the cost of treating neurological patients is approaching $1T annually**.
The shortage of neurologists (1 per 23,259 people) is a “grave threat”*** as the supply has remained relatively constant.
In addition to the provider shortage, sub-optimal workflows and ineffective therapeutic options further constrain patient throughput.
*New global action plan on epilepsy and other neurological disorders published. (n.d.). Retrieved from https://www.who.int/news/item/20-07-2023-new-global-action-plan-on-epilepsy-and-other-neurological-disorders-published
**Sidhu and Kateb, J Neurol Disord 2014, 2:6, DOI: 10.4172/2329-6895.1000e113
https://www.hilarispublisher.com/open-access/world-brain-mapping-and-therapeutic-initiative-a-proposed-g-priority-due-to-major-impact-of-the-cost-of-neurological-disorders-on-the-world-economy-2329-6895-2-e113.pdf
***American Academy of Neurology